Jeff Yass’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Jeff Yass's RAPP Position: Q3 2026 in Review
Jeff Yass increased its Rapport Therapeutics (RAPP) stake by 91% in Q3 2026, buying an estimated $323K and bringing the position to 15,746 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #9611.
Jeff Yass first reported a position in RAPP in Q1 2025 and has held it in 7 quarters since. The position peaked at $628K in Q3 2025. 167 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Jeff Yass held 15,746 shares of Rapport Therapeutics worth $529K as of Q3 2026.
- Jeff Yass bought 7,491 Rapport Therapeutics shares in Q3 2026, an estimated $323K.
- Rapport Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9611 holding.
- Jeff Yass first reported a position in Rapport Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Jeff Yass's Rapport Therapeutics position peaked at $628K in Q3 2025.
- 167 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.